Effect of warfarin nonadherence on control of the International Normalized Ratio

American Journal of Health-System Pharmacy

Volumn 61, Issue 12, 2004, Pages 1258-1264

  Waterman, Amy D ^a,d   Milligan, Paul E ^a   Bayer, Laura ^b   Banet, Gerald A ^c   Gatchel, Susan K ^c   Gage, Brian F ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Compreh Neuropsychological Services ^*  (United States)

^c Section of Trauma Burns and Critical Care   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

Age; Anticoagulants; Compliance; Geriatrics; International Normalized Ratio; Patients; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; CONTROLLED STUDY; DEMOGRAPHY; DIET RESTRICTION; FEMALE; HEALTH STATUS; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW;

EID: 8344278869     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.12.1258     Document Type: Review

References (49)

1. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003; 289: 1107-16.
2. Go AS, Hylek EM, Borowsky LH et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Ann Intern Med. 1999; 131:927-34.
3. Gage BF, Boechler M, Doggette AL et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation. Stroke. 2000; 31:822-7.
4. Hirsh J, Dalen J, Anderson DR et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001; 119(1, suppl): 8S-21S.
5. Hamby L, Weeks WB, Malikowski C. Complications of warfarin therapy: causes, costs, and the role of the anticoagulation clinic. Eff Clin Pract. 2000; 3(4):179-84.
6. Chisholm MA. Enhancing transplant patients' adherence to medication therapy. Clin Transpl. 2002; 16(1):30-8.
7. Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med. 1997; 103:11-7.
8. Rudnicka AR, Ashby D, Brennan P et al. Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect. Arch Intern Med. 2003; 163:1454-60.
9. Nattinger AB, Kneusel RT, Hoffmann RG et al. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst. 2001; 93:1344-6.
10. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990; 150: 841-5.
11. Barr RG, Somers SC, Speizer FE et al. Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med. 2002; 162: 1761-8.
12. Waterman AD, Milligan PE, Banet GA et al. Establishing and running an effective telephone-based anticoagulation service. J Vasc Nurs. 2001; 19(4):126-32.
13. Rosendaal FR, Cannegieter SC, van der Meer FJ et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993; 69:236-9.
14. Banet GA, Waterman AD, Milligan PE et al. Warfarin dose reduction vs watchful waiting for mild elevations in the International Normalized Ratio. Chest. 2003; 123:499-503.
15. Kleinbaum DG. Survival analysis: a self-learning text. New York: Springer; 1996.
16. White RH, Beyth RJ, Zhou H et al. Major bleeding after hospitalization for deep-venous thrombosis. Am J Med. 1999; 107: 414-24.
17. Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet. 1996; 348:423-8.
18. Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285:2864-70.
19. Schwartz D, Wang M, Zeitz L et al. Medication errors made by elderly, chronically ill patients. Am J Public Health. 1962; 52: 2018-29.
20. Monane M, Bohn RL, Gurwitz JH et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996; 86:1805-8.
21. Coons SJ, Sheahan SL, Martin SS et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther. 1994; 16(1):110-7.
22. Ansell J, Hirsh J, Dalen J et al. Managing oral anticoagulant therapy. Chest. 2001; 119(1, suppl):22S-38S.
23. Peterson AM, Takiya L, Finley R. Metaanalysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003; 60:657-65.
24. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med. 2000; 133:687-95.
25. Hulka BS, Cassel JC, Kupper LL et al. Communication, compliance, and concordance between physicians and patients with prescribed medications. Am J Public Health. 1976; 66:847-53.
26. Cromheecke ME, Levi M, Colly LP et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet. 2000; 356:97-102.
27. Kulinna W, Ney D, Wenzel T et al. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin Thromb Hemost. 1999; 25(1):123-6.
28. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-management of Oral Anticoagulation. JAMA. 1999; 281: 145-50.
29. Roter DL, Hall JA, Merisca R et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998; 36:1138-61.
30. Calcagno DM, Carey R. Improving patient satisfaction with warfarin management. Am J Manag Care. 1996; 2:804-10.
31. Haynes RB, Taylor DW, Sackett DL et al. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980; 2:757-64.
32. Craig HM. Accuracy of indirect measures of medication compliance in hypertension. Res Nurs Health. 1985; 8(1):61-6.
33. Fletcher SW, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin. Arch Intern Med. 1979; 139:635-8.
34. Grymonpre RE, Didur CD, Montgomery PR et al. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998; 32:749-54.
35. Liu H, Golin CE, Miller LG et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001; 134:968-77.
36. Monane M, Bohn RL, Gurwitz JH et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997; 10(7, pt. 1):697-704.
37. Kumar S, Haigh JR, Rhodes LE et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost. 1989; 62:729-32.
38. Brigden ML, Kay C, Le A et al. Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population. Am J Hematol. 1998; 59(1):22-7.
39. Petersen P, Boysen G, Godtfredsen J et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989; 1: 175-9.
40. Van den Besselaar AM, van der Meer FJ, Gerrits-Drabbe CW. Therapeutic control of oral anticoagulant treatment in the Netherlands. Am J Clin Pathol 1988; 90: 685-90.
41. Cannegieter SC, Rosendaal FR, Wintzen AR et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995; 333:11-7.
42. European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med. 1995; 333:5-10.
43. Rospond RM, Quandt CM, Clark GM et al. Evaluation of factors associated with stability of anticoagulation therapy. Pharmacotherapy. 1989; 9:207-13.
44. Kumar S, Haigh JR, Davies JA et al. Apparent warfarin resistance due to poor compliance. Clin Lab Haematol. 1989; 11 (2):161-3.
45. Hixson-Wallace JA, Dotson JB, Blakey SA. Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clin Appl Thromb Hemost. 2001; 7(1):33-7.
46. Van der Meer FJ, Briet E, Vandenbroucke JP et al. The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol. 1997; 98:893-900.
47. Casais P, Luceros AS, Meschengieser S et al. Bleeding risk factors in chronic oral anticoagulation with acenocoumarol. Am J Hematol. 2000; 63(4):192-6.
48. Fihn SD, McDonell M, Martin D et al. Risk factors for complications of chronic anticoagulation. A multi-center study. Ann Intern Med. 1993; 118:511-20.
49. Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during anti-thrombotic therapy in patients with atrial fibrillation. Arch Intern Med. 1996; 156: 409-16.